Mbio Pharmaceuticals, Inc.
MBMINDBODY is a leading provider of cloud-based business management software and a two-sided marketplace for the wellness services industry.
Table of contents
Competitors
By market cap
By revenue growth
Profile
MINDBODY is a leading provider of cloud-based business management software and a two-sided marketplace for the wellness services industry. The company offers an integrated platform that enables wellness businesses to manage operations, payments, and marketing while providing consumers a mobile interface to discover, book, and pay for wellness activities. Its core value proposition centers on increasing business capacity utilization and consumer engagement through data-driven tools like dynamic pricing.
A dominant player in the wellness niche, leveraging a two-sided network effect between a large practitioner base and millions of registered consumers.
Questions, answered.
- What is Mbio Pharmaceuticals, Inc.'s market cap?
- Mbio Pharmaceuticals, Inc. (MB) has a market capitalization of $69.1M and trades on XNAS.
- Who are Mbio Pharmaceuticals, Inc.'s competitors?
- Mbio Pharmaceuticals, Inc.'s key competitors include Microsoft, Google, EverCommerce Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does Mbio Pharmaceuticals, Inc. partner with?
- Mbio Pharmaceuticals, Inc.'s notable partners include Google, Bing.
- Where is Mbio Pharmaceuticals, Inc. headquartered?
- Mbio Pharmaceuticals, Inc. is headquartered in Hong Kong. It has been publicly traded since 2025.